6h
House Digest on MSN14 Fragrant Pastel Annuals To Give Your Containers A Touch Of Romance This SpringFragrant flowers are perfect anywhere in the garden, but when you grow them in containers, you can place them around your ...
Alnylam (ALNY) saw its shares surge in the last session with trading volume being higher than average. The latest trend in ...
University of California Cooperative Extension UCCE Offices are local problem-solving centers, part of a statewide network of ...
Like most gardeners, I have favorite plants I’ve been growing for years and will continue to grow, like fragrant and tasty ...
Dianthus Therapeutics (NASDAQ:DNTH – Get Free Report) is expected to be issuing its quarterly earnings data before the market ...
HC Wainwright reaffirmed their buy rating on shares of Dianthus Therapeutics (NASDAQ:DNTH – Free Report) in a report issued ...
Given this risk, we thought we'd take a look at whether Dianthus Therapeutics (NASDAQ:DNTH) shareholders should be worried about its cash burn. For the purposes of this article, c ...
Full Year 2024 Results Key Financial Results Net loss: US$85.0m (loss widened ...
Advice from top interior designers (and real-life renovators) on what to do and what not to do when tackling the bathroom ...
- Tau silencing gene therapy VY1706 robustly reduced tau mRNA levels, with broad distribution, and was well-tolerated in NHP ...
13d
Zacks Investment Research on MSNDianthus Therapeutics, Inc. (DNTH) Reports Q4 Loss, Misses Revenue EstimatesDianthus Therapeutics, Inc. (DNTH) came out with a quarterly loss of $0.81 per share versus the Zacks Consensus Estimate of a loss of $0.85. This compares to loss of $0.71 per share a year ago. These ...
Reports Q4 revenue $1.33M, consensus $859,700. “We remain on track to report top-line data in 2H’25 from our Phase 2 clinical trial of DNTH103 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results